Literature DB >> 24577898

Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats.

Mohsen Shirazi1, Mahin Izadi, Masoud Amin, Mohammad Ebrahim Rezvani, Ali Roohbakhsh, Ali Shamsizadeh.   

Abstract

Transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel that is involved in modulation of diverse physiological processes. The role of this receptor in epilepsy has not been studied well. Therefore, we investigated the role of central TRPV1 receptors on the development of pentylenetetrazole (PTZ) and amygdala-induced kindling in rats. Male Wistar rats received subconvulsive dose of PTZ intraperitoneally, every other day. TRPV1 receptor agonist, OLDA and its antagonist, AMG-9810 were injected intracerebroventricularly 30 min prior to PTZ administration. In electrical kindling, stimulating and recording electrodes were implanted in the right amygdala of male rats. After kindling, the effect of TRPV1 receptor agonist or antagonist on afterdischarge duration (ADD), latency to the onset of bilateral forelimb clonuses (S4L) and duration of loss of equilibrium (stage 5 seizures, S5D) were measured. The results demonstrated that, OLDA at the doses of 0.01, 0.1 and 1 μg/rat, significantly accelerated the incidence of all seizure stages, increased S5D and decreased S4L in the PTZ model of kindling. Also, in amygdala kindling, S5D and ADD were significantly reduced following the administration of AMG-9810. In contrast, OLDA significantly aggravated the indices of seizure in both models of epileptic seizure. This study demonstrated that central TRPV1 receptors may be involved in the development of electrical and PTZ-induced kindling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577898     DOI: 10.1007/s10072-014-1689-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  22 in total

1.  Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.

Authors:  S W Hwang; H Cho; J Kwak; S Y Lee; C J Kang; J Jung; S Cho; K H Min; Y G Suh; D Kim; U Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control.

Authors:  Nicole M Rowley; Karsten K Madsen; Arne Schousboe; H Steve White
Journal:  Neurochem Int       Date:  2012-02-18       Impact factor: 3.921

3.  Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures.

Authors:  Shyamshree S S Manna; Sudhir N Umathe
Journal:  Epilepsy Res       Date:  2012-03-03       Impact factor: 3.045

Review 4.  Animal models used in the screening of antiepileptic drugs.

Authors:  H Kupferberg
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

Review 5.  Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.

Authors:  Wolfgang Löscher
Journal:  Seizure       Date:  2011-02-02       Impact factor: 3.184

6.  Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.

Authors:  L Cristino; L de Petrocellis; G Pryce; D Baker; V Guglielmotti; V Di Marzo
Journal:  Neuroscience       Date:  2006-04-17       Impact factor: 3.590

7.  Anticonvulsant and depressant effects of aqueous extracts of Carum copticum seeds in male rats.

Authors:  Mohammad Ebrahim Rezvani; Ali Roohbakhsh; Mohammad Hossein Mosaddegh; Mansour Esmailidehaj; Fatemeh Khaloobagheri; Hossein Esmaeili
Journal:  Epilepsy Behav       Date:  2011-08-16       Impact factor: 2.937

8.  Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain.

Authors:  Attila Tóth; Judit Boczán; Noémi Kedei; Erzsébet Lizanecz; Zsolt Bagi; Zoltán Papp; István Edes; László Csiba; Peter M Blumberg
Journal:  Brain Res Mol Brain Res       Date:  2005-01-22

9.  TRPV1: a potential target for antiepileptogenesis.

Authors:  Min Fu; Zuoping Xie; Huancong Zuo
Journal:  Med Hypotheses       Date:  2009-03-27       Impact factor: 1.538

10.  Spinal NKCC1 blockade inhibits TRPV1-dependent referred allodynia.

Authors:  Mark H Pitcher; Theodore J Price; Jose M Entrena; Fernando Cervero
Journal:  Mol Pain       Date:  2007-06-30       Impact factor: 3.395

View more
  9 in total

Review 1.  Molecular Targets of Cannabidiol in Neurological Disorders.

Authors:  Clementino Ibeas Bih; Tong Chen; Alistair V W Nunn; Michaël Bazelot; Mark Dallas; Benjamin J Whalley
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Inhibition of transient potential receptor vanilloid type 1 suppresses seizure susceptibility in the genetically epilepsy-prone rat.

Authors:  Sue J Cho; Michelle A Vaca; Clive J Miranda; Prosper N'Gouemo
Journal:  CNS Neurosci Ther       Date:  2017-11-03       Impact factor: 5.243

3.  The Role of the Possible Receptors and Intracellular Pathways in Protective Effect of Exogenous Anandamide in Kindling Model of Epilepsy.

Authors:  Sepideh Khaksar; Mona Salimi; Hadi Zeinoddini; Nima Naderi
Journal:  Neurochem Res       Date:  2022-02-03       Impact factor: 3.996

4.  Increased TRPV1 Channels and FosB Protein Expression Are Associated with Chronic Epileptic Seizures and Anxiogenic-like Behaviors in a Preclinical Model of Temporal Lobe Epilepsy.

Authors:  Willian Lazarini-Lopes; Gleice Kelli Silva-Cardoso; Christie Ramos Andrade Leite-Panissi; Norberto Garcia-Cairasco
Journal:  Biomedicines       Date:  2022-02-10

Review 5.  Cannabinoids and the expanded endocannabinoid system in neurological disorders.

Authors:  Luigia Cristino; Tiziana Bisogno; Vincenzo Di Marzo
Journal:  Nat Rev Neurol       Date:  2019-12-12       Impact factor: 42.937

6.  α-Spinasterol, a TRPV1 receptor antagonist, elevates the seizure threshold in three acute seizure tests in mice.

Authors:  Katarzyna Socała; Dorota Nieoczym; Mateusz Pieróg; Piotr Wlaź
Journal:  J Neural Transm (Vienna)       Date:  2015-03-13       Impact factor: 3.575

Review 7.  TRPV1 Channel: A Potential Drug Target for Treating Epilepsy.

Authors:  Mustafa Nazıroğlu
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 8.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

Review 9.  Climate change and epilepsy: Insights from clinical and basic science studies.

Authors:  Medine I Gulcebi; Emanuele Bartolini; Omay Lee; Christos Panagiotis Lisgaras; Filiz Onat; Janet Mifsud; Pasquale Striano; Annamaria Vezzani; Michael S Hildebrand; Diego Jimenez-Jimenez; Larry Junck; David Lewis-Smith; Ingrid E Scheffer; Roland D Thijs; Sameer M Zuberi; Stephen Blenkinsop; Hayley J Fowler; Aideen Foley; Sanjay M Sisodiya
Journal:  Epilepsy Behav       Date:  2021-02-10       Impact factor: 3.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.